Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovative targeted therapeutics to specifically treat ESR1-mutated
ZeroFox (Nasdaq: ZFOX), a leading external cybersecurity provider, will exhibit at Black Hat Middle East and Africa (MEA), which runs Nov. 15-17 at Riyadh Front